deoxyuridine has been researched along with Kahler Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morgenroth, A; Mottaghy, FM; Oedekoven, C; Siluschek, M; Vogg, AT; Zlatopolskiy, BD | 1 |
Al-Momani, E; Dinger, C; Glatting, G; Morgenroth, A; Mottaghy, FM; Reske, SN; Zlatopolskiy, BD | 1 |
Hansen, OP | 1 |
3 other study(ies) available for deoxyuridine and Kahler Disease
Article | Year |
---|---|
Breaking the invulnerability of cancer stem cells: two-step strategy to kill the stem-like cell subpopulation of multiple myeloma.
Topics: Apoptosis; Cell Line, Tumor; Cell Lineage; Deoxyuridine; DNA Damage; Enzyme Inhibitors; Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Thymidylate Synthase | 2014 |
Auger electron emitter against multiple myeloma--targeted endo-radio-therapy with 125I-labeled thymidine analogue 5-iodo-4'-thio-2'-deoxyuridine.
Topics: Apoptosis; Biological Transport; Caspase 3; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyuridine; DNA; DNA Fragmentation; Drug Resistance, Neoplasm; Electrons; Humans; Insulin-Like Growth Factor I; Interleukin-6; Molecular Targeted Therapy; Multiple Myeloma; Neoplasm Staging; Thymidine | 2011 |
Bone marrow studies in myelomatosis.
Topics: Adult; Aged; Bone Marrow; Deoxyuridine; Female; Folic Acid; Formiminoglutamic Acid; Glomerular Filtration Rate; Humans; Iron; Male; Middle Aged; Multiple Myeloma; Plasma Cells; Vitamin B 12 | 1978 |